Published in Am J Clin Nutr on November 01, 2008
Mediterranean diet and prostate cancer risk and mortality in the Health Professionals Follow-up Study. Eur Urol (2013) 1.59
Consumption of fish products across the lifespan and prostate cancer risk. PLoS One (2013) 1.46
Lifestyle as risk factor for cancer: Evidence from human studies. Cancer Lett (2010) 1.35
Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy. Cancer Prev Res (Phila) (2011) 1.23
Index-based dietary patterns and the risk of prostate cancer in the NIH-AARP diet and health study. Am J Epidemiol (2013) 1.12
Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer. Neoplasia (2010) 1.02
Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr (2009) 1.01
Polymorphisms in carcinogen metabolism enzymes, fish intake, and risk of prostate cancer. Carcinogenesis (2012) 0.99
The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era. Int J Cancer (2015) 0.98
Consumption of high ω-3 fatty acid diet suppressed prostate tumorigenesis in C3(1) Tag mice. Carcinogenesis (2011) 0.97
A critical review of Vitamin D and Cancer: A report of the IARC Working Group. Dermatoendocrinol (2009) 0.96
Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies. J Natl Cancer Inst (2014) 0.94
Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer. Cancer Causes Control (2010) 0.92
Dietary n-3 polyunsaturated fatty acids fail to reduce prostate tumorigenesis in the PB-ErbB-2 x Pten(+/-) preclinical mouse model. Cell Cycle (2010) 0.91
Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence. Biomed Res Int (2015) 0.90
Omega-3 fatty acids, genetic variants in COX-2 and prostate cancer. J Nutrigenet Nutrigenomics (2009) 0.88
Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation. PLoS One (2011) 0.87
Relationship of dietary intake of omega-3 and omega-6 Fatty acids with risk of prostate cancer development: a meta-analysis of prospective studies and review of literature. Prostate Cancer (2012) 0.86
Diet and lifestyle factors associated with fish consumption in men and women: a study of whether gender differences can result in gender-specific confounding. Nutr J (2012) 0.85
Erythrocyte fatty acids and prostate cancer risk: a comparison of methods. Prostaglandins Leukot Essent Fatty Acids (2010) 0.82
What should we tell prostate cancer patients about (secondary) prevention? Curr Opin Urol (2014) 0.82
Meta-Analysis of Long-Chain Omega-3 Polyunsaturated Fatty Acids (LCω-3PUFA) and Prostate Cancer. Nutr Cancer (2015) 0.81
Blood level omega-3 Fatty acids as risk determinant molecular biomarker for prostate cancer. Prostate Cancer (2013) 0.80
Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies. Int J Cancer (2016) 0.80
Effect of a low-fat fish oil diet on proinflammatory eicosanoids and cell-cycle progression score in men undergoing radical prostatectomy. Cancer Prev Res (Phila) (2013) 0.79
A pilot study to investigate if New Zealand men with prostate cancer benefit from a Mediterranean-style diet. PeerJ (2015) 0.77
Antiproliferative activities of Fagara xanthoxyloides and Pseudocedrela kotschyi against prostate cancer cell lines. Anticancer Res (2015) 0.76
Blood fatty acid patterns are associated with prostate cancer risk in a prospective nested case-control study. Cancer Causes Control (2016) 0.75
Proteomic approaches to predict bioavailability of fatty acids and their influence on cancer and chronic disease prevention. J Nutr (2012) 0.75
Diet, Lifestyles, Family History, and Prostate Cancer Incidence in an East Algerian Patient Group. Biomed Res Int (2016) 0.75
The Association of Fatty Acid Levels and Gleason Grade among Men Undergoing Radical Prostatectomy. PLoS One (2016) 0.75
Components of an anticancer diet: dietary recommendations, restrictions and supplements of the Bill Henderson Protocol. Nutrients (2010) 0.75
Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol (1992) 17.17
Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med (1989) 13.83
Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med (1996) 8.57
Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr (2004) 3.01
Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst (1994) 2.68
Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr (2001) 2.64
Role of diet in prostate cancer development and progression. J Clin Oncol (2005) 2.29
Fatty fish consumption and risk of prostate cancer. Lancet (2001) 2.27
Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res (1990) 2.21
A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res (1989) 2.18
A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2007) 1.94
Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am J Clin Nutr (2004) 1.94
Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer (1989) 1.91
Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids (2003) 1.78
Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci U S A (1998) 1.74
A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomarkers Prev (2003) 1.73
Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States). Cancer Causes Control (2006) 1.67
Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma. Cancer Epidemiol Biomarkers Prev (1996) 1.64
Prostate cancer risk and consumption of fish oils: a dietary biomarker-based case-control study. Br J Cancer (1999) 1.58
A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.53
Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer. Int J Cancer (1997) 1.45
Fatty acids and risk of prostate cancer in a nested case-control study in male smokers. Cancer Epidemiol Biomarkers Prev (2003) 1.35
Meat and dairy consumption and subsequent risk of prostate cancer in a US cohort study. Cancer Causes Control (2007) 1.34
Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun (1997) 1.31
Animal products, calcium and protein and prostate cancer risk in The Netherlands Cohort Study. Br J Cancer (1999) 1.31
Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr (2008) 1.30
Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate (1991) 1.24
Early life risk factors for prostate cancer: a population-based case-control study in Sweden. Cancer Epidemiol Biomarkers Prev (1995) 1.20
Association of energy and fat intake with prostate carcinoma risk: results from The Netherlands Cohort Study. Cancer (1999) 1.19
Serum linoleic and total polyunsaturated fatty acids in relation to prostate and other cancers: a population-based cohort study. Int J Cancer (2004) 1.18
Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control (2004) 1.18
Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy. Neoplasia (2006) 1.16
The association of fatty acids with prostate cancer risk. Prostate (2001) 1.10
A prospective study of dietary calcium, dairy products and prostate cancer risk (Finland). Int J Cancer (2007) 1.07
Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2002) 1.04
Associations of demographic and health-related characteristics with prostate cancer screening in Washington State. Cancer Epidemiol Biomarkers Prev (1998) 1.03
Foods, nutrients and prostate cancer: a case-control study in Uruguay. Br J Cancer (1999) 1.02
15-lipoxygenase metabolites of gamma-linolenic acid/eicosapentaenoic acid suppress growth and arachidonic acid metabolism in human prostatic adenocarcinoma cells: possible implications of dietary fatty acids. Prostaglandins Leukot Essent Fatty Acids (2005) 0.99
Effects of docosahexaenoic acid and eicosapentaenoic acid on androgen-mediated cell growth and gene expression in LNCaP prostate cancer cells. Carcinogenesis (2001) 0.97
Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice. Nutr Cancer (1997) 0.96
A dietary intervention for recurrent prostate cancer after definitive primary treatment: results of a randomized pilot trial. Urology (2008) 0.95
Recreational physical activity and prostate cancer risk (United States). Cancer Causes Control (2006) 0.91
Expression of 5-oxoETE receptor in prostate cancer cells: critical role in survival. Biochem Biophys Res Commun (2005) 0.91
Dietary n-3 polyunsaturated fatty acids enhance hormone ablation therapy in androgen-dependent prostate cancer. Am J Pathol (2008) 0.90
Inverse association between prostatic polyunsaturated fatty acid and risk of locally advanced prostate carcinoma. Cancer (2004) 0.88
Diagnosis, staging, and surgical treatment of prostatic carcinoma. Arch Intern Med (1987) 0.82
Prostatic fatty acids and cancer recurrence after radical prostatectomy for early-stage prostate cancer. Cancer Causes Control (2007) 0.81
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature (2007) 17.68
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med (2008) 12.41
Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA (2004) 11.69
Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med (2009) 10.54
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature (2008) 10.12
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature (2012) 9.89
Large-scale sequence analysis of avian influenza isolates. Science (2006) 9.87
Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science (2008) 9.25
A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med (2003) 9.24
Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med (2004) 8.63
A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care (2003) 7.40
Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med (2002) 7.32
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19
Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96
Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr (2005) 6.67
Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation (2003) 6.62
Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature (2011) 6.39
A prospective study of sleep duration and mortality risk in women. Sleep (2004) 6.11
Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet (2011) 6.06
Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med (2003) 5.95
Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86
Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med (2004) 5.67
Alternative dietary indices both strongly predict risk of chronic disease. J Nutr (2012) 5.60
Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med (2005) 5.59
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med (2014) 5.37
CREST maps somatic structural variation in cancer genomes with base-pair resolution. Nat Methods (2011) 5.34
Obesity, weight gain, and the risk of kidney stones. JAMA (2005) 5.34
Physical activity and weight gain prevention. JAMA (2010) 5.27
Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 5.25
Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature (2011) 5.20
Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 5.13
Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med (2010) 5.05
A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature (2012) 5.02
Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science (2012) 4.92
Novel mutations target distinct subgroups of medulloblastoma. Nature (2012) 4.82
Red meat consumption and mortality: results from 2 prospective cohort studies. Arch Intern Med (2012) 4.72
Exercise type and intensity in relation to coronary heart disease in men. JAMA (2002) 4.69
Vasectomy and risk of aggressive prostate cancer: a 24-year follow-up study. J Clin Oncol (2014) 4.67
Merging and emerging cohorts: not worth the wait. Nature (2007) 4.66
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature (2011) 4.57
Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care (2002) 4.48
Habitual caffeine intake and the risk of hypertension in women. JAMA (2005) 4.46
Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell (2012) 4.41
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med (2011) 4.37
Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. Nat Genet (2009) 4.35
Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med (2002) 4.21
Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med (2002) 4.19
Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA (2004) 4.04
Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst (2006) 3.96
Association of nut consumption with total and cause-specific mortality. N Engl J Med (2013) 3.94
Diet and lifestyle risk factors associated with incident hypertension in women. JAMA (2009) 3.94
Estimating the number of deaths due to obesity: can the divergent findings be reconciled? J Womens Health (Larchmt) (2007) 3.86
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation (2005) 3.85
Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized, Controlled Trial. Ann Intern Med (2015) 3.78
Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer (2007) 3.77
Gene expression profiling of pediatric acute myelogenous leukemia. Blood (2004) 3.77
CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature (2011) 3.72
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Smoking and smoking cessation in relation to mortality in women. JAMA (2008) 3.68
Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA (2002) 3.68
Major dietary protein sources and risk of coronary heart disease in women. Circulation (2010) 3.65
Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol (2008) 3.62
Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA (2002) 3.60
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst (2008) 3.55
Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst (2003) 3.54
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet (2013) 3.51
Prospective study of sudden cardiac death among women in the United States. Circulation (2003) 3.45
The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet (2013) 3.43
Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch Intern Med (2004) 3.42
Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation (2006) 3.39
Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol (2009) 3.32
A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst (2004) 3.32
Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA (2004) 3.31
The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell (2013) 3.27
Diabetes mellitus and the risk of nephrolithiasis. Kidney Int (2005) 3.17
Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 3.11
A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res (2007) 3.08
Theoretical studies on the magnetic switching controlled by stacking patterns of bis(maleonitriledithiolato) nickelate(III) dimers. J Am Chem Soc (2005) 3.07
Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care (2006) 3.06
Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst (2002) 3.03
Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr (2002) 3.00
Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol (2008) 2.96
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol (2009) 2.94
Active and passive smoking in breast cancer: prospective results from the Nurses' Health Study. Epidemiology (2002) 2.86
Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst (2011) 2.85
Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation (2002) 2.78
Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt) (2006) 2.77
A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment. Cancer Discov (2011) 2.77
Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol (2002) 2.75
Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev (2004) 2.75
Mercury and the risk of coronary heart disease in men. N Engl J Med (2002) 2.71